The Washington Post

Amid backlash, FDA changes course over shortage of weight-loss drugs

[ad_1]

The FDA said Eli Lilly’s weight-loss drugs were no longer in shortage on Oct. 2, preventing pharmacies from making cheaper versions. After an outcry, it’s reconsidering.

[ad_2]

Source link : https://www.washingtonpost.com/business/2024/10/19/weight-loss-drugs-fda-eli-lilly/

Author : Daniel Gilbert

Publish date : 2024-10-19 16:00:00

Copyright for syndicated content belongs to the linked Source.

Tags : The Washington Post